The Turkish company OnkoResult (a subsidiary of Pharmaline) has conducted DR-70 clinical trials in the past two or three years, and the results have exceeded expectations, with the support of many local doctors and teaching hospitals; In April, we will actively strive for the government budget to implement the colorectal cancer tracking and screening program of the National People, and gradually apply it to other cancers, and at the same time assist the company in promoting DR-70 to neighboring countries.
